Basic Information
| LncRNA/CircRNA Name | LINC01793 |
| Synonyms | NA |
| Region | GRCh38_2:59217708-59279400 |
| Ensemble | ENSG00000222030 |
| Refseq | NR_110219 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qRT-PCR, ect. |
| Sample | gastric cancer cells, Gastric cancer tissues and paracancerous tissues |
| Expression Pattern | up-regulated |
| Function Description | LINC01793 was overexpressed in gastric cancer tissues compared to paracancerous tissues. Moreover, LINC01793 overexpression in gastric cancer was closely related to patients with poor prognosis. GSEA analysis found that LINC01793 was closely related to apoptosis, cell cycle, invasion and metastasis of gastric cancer cells. |
| Pubmed ID | 29978448 |
| Year | 2018 |
| Title | Overexpression of lncRNA LINC01793 acts as a potential predictor for progression and poor prognosis of gastric cancer. |
External Links
| Links for LINC01793 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |